A prospective, non-randomised study of chemotherapy and radiotherapy for osteolymphoma (OL)
Completed
- Conditions
- OsteolymphomaCancer - Bone
- Registration Number
- ACTRN12607000111471
- Lead Sponsor
- David Christie
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
Histologically confirmed non-Hodgkin’s lymphoma in a bony site - Limited extraosseous disease - Ann Arbor stage IE Age >17- ECOG performance status >3 - Expected survival > 6 months - Written informed consent
Exclusion Criteria
Previous radiotherapy or chemotherapy- Previous malignancy - Medically unfit to undergo treatment
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method